NVCR — NovoCure Limited
7 mentions in the last 24 hours · 0.03% of all mentions
NVCR — 오늘 왜 언급됐나 (2026-10-29)
- 버라스템 온콜로지와 췌장암 치료를 위한 임상 협력 및 공급 계약을 체결했다.
Why people talked about NVCR
- NovoCure reported Q3 2026 revenue of $193.4M and EPS of -$0.09, beating estimates.
- The company raised its full-year 2026 guidance and announced an 18% revenue growth.
- NovoCure signed a clinical collaboration with Verastem Oncology for pancreatic cancer treatment.
| Bluesky | 5 | community |
| GDELT | 1 | news |
| SEC EDGAR 8-K | 1 | filings |